Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

Abstracts by keywords: Statutory health insurance

Trust, image and credibility: dormant potential of GKVn supply management

In an increasingly volatile and fast-moving time, brands are becoming more and more important for consumers - also in their role as health insured people. However, if the brand image created by the company does not match the actual brand identity, dissonances occur with counterproductive effects. An aspect that is becoming more important than ever for statutory health insurance companies (GKVn), among other things due to the resulting market confusion and product diversity.

02.10.2012
Influence of insurance status and income on waiting time in outpatient care

Influence of insurance status and income on waiting times in the outpatient sector. The length of the waiting time for an appointment in the outpatient and inpatient sectors is considered an important quality indicator and a significant parameter for access to medical care in most countries. Since waiting times are often perceived as an implicit form of rationing of healthcare services, this […]

25.09.2012
Health care research is absolutely necessary from a medical and regulatory perspective

Many scientific innovations are developed in the field of basic research and then, based on the results of in-vitro research, are so solidly processed through small animal experiments that the path to applying these processes to humans is cleared. Further clinical research deals with measuring the effect of the therapeutic procedure and the side effects and at the same time lays the foundation for the approval procedures of the relevant authorities in North America and Europe. In order to be able to measure the effectiveness of therapeutic procedures, special patient groups are often put together in order to measure the effect of the new procedure/medication on a placebo procedure or on other, often older, medications or medical procedures/procedures in prospective randomized studies. A fundamental bias in these studies is often a strictly selected patient population that only slightly corresponds to the overall “real world” population addressed under field conditions.

07.02.2011

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.